top of page
Developing a safe, convenient, disease-modifying treatment for everyone with peanut allergy.
Management Team
Dr Sara Prickett
(BSc, PhD)
Chief Scientific Officer
Dr Pascal Hickey
(BPharm, PhD)
Chief Executive Officer
Dr Paul Laidler
(BPharm, PhD)
Director Product Development
Judy Bingham
(BPharm, MHA)
Director Regulatory Operations
Dr Andrew Humberstone
(BPharm, PhD)
Director Clinical Development
Dr Matthew Moyle
(BSc, PhD)
Head, Commercial Development
Annette Leahy
(BHIM)
Director Clinical Operations
bottom of page